semaglutide poster Patient Booklet - Canva Editable Scientific Poster: Resmetirom and Semaglutide

OSA is a highly prevalent condition, strongly associated with obesity and linked to an increased risk of cardiovascular disease

Learn the three strategies.

Discover the key differences in how these popular weight-loss treatments work and how effective they are, and find out which option is right for you.

Learn about self-pay programs, telehealth options, and cost-saving tips.

Positive findings from a phase III trial of semaglutide in metabolic dysfunction-associated steatohepatitis (MASH) is moving Novo Nordisk A/S to expand the glucagon-like peptide-1 (GLP-1) agonists indications in the U.S

Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset, and the lasting habits that can help keep weight off for goodPRINCETON, N.J., June 24, 2026 (GLOBE NEWSWIRE) -- Noom, the leading behavior change company trusted by millions, today announced the launch of its free GLP-1 Companion program, now available at no cost to anyone taking a GLP-1 medication, regardless of provider